在使用双变量探针模型的剂量定位研究中,针对疗效-毒性反应的最佳设计.
Belmiro P M Duarte1, Anthony C Atkinson2
1Polytechnic Institute of Coimbra, ISEC, Department of Chemical & Biological Engineering, Rua Pedro Nunes, 3030-199 Coimbra, Portugal; University of Coimbra, INESC-Coimbra, Rua Sílvio Lima - Pólo II, 3030-790 Coimbra, Portugal; University of Coimbra, CERES, Department of Chemical Engineering, Rua Sílvio Lima - Pólo II, 3030-790 Coimbra, Portugal.
本研究介绍了扩展I期临床试验的最佳实验设计,重点关注药物的疗效和毒性. 这些方法使用双变量探头模型和半确定的编程来获得相关的响应.
科学领域:
- 临床试验的设计
- 生物统计学 生物统计学
- 实验设计 实验设计
背景情况:
- 一期临床试验传统上优先考虑药物安全性和最大耐受剂量的确定.
- 在I期研究中,有效性评估往往是次要的目标.
- 扩展的第一阶段试验为同时评估疗效和毒性提供了机会.
研究的目的:
- 为扩展I期临床试验开发最佳的实验设计.
- 解决药物的疗效和毒性都被测量和相关的情况.
- 调查相关性,先验知识,约束和药物组合对设计最佳性的影响.
主要方法:
- 使用双变量探针模型来表示相关的疗效和毒性反应.
- 采用半确定的编程来构建局部最佳的实验设计.
- 考虑了各种场景,包括相关性强度,已知与未知相关性,设计约束以及单一与组合药物.
- 应用的D,A,E和K最佳性标准.
主要成果:
- 在扩展的第一阶段试验中开发了系统的数值方法,以实现最佳的实验设计.
- 使用等价定理证明了拟议设计的最佳性.
- 专门为K-最佳性标准推导了一个等价定理.
- 展示了该方法在各种设计考虑中的适应性.
结论:
- 拟议的基于半定义编程的方法提供了一个强大的框架,用于优化扩展的I期临床试验中的实验设计.
- 这些发现为在药物开发早期阶段平衡疗效和安全性评估提供了实际见解.
- 开发的设计可以适应各种相关结构,约束和药物组合,提高试验效率.
更多相关视频
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023
09:12Optimization of Processing of Tiebangchui with Highland Barley Wine Based on the Box-Behnken Design Combined with the Entropy Method
Published on: May 19, 2023
相关概念视频
Dose-Response Relationship: Overview
Dose-Response Relationship: Potency and Efficacy
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Odds Ratio
